Ngozi Eboru
Psychiatric/Mental Health · Joliet, ILNPI 1033861067
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $16,500 of the $23,726 with a category attached, or 69.5%. Johnson & Johnson accounts for 81.5% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $20,205, more than ten times the $256 reported in 2022. Among psychiatric/mental health clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 160 payments — averaging $148.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$19K
- Neurocrine Biosciences, Inc.$830
- Alkermes, Inc.$678
- Otsuka America Pharmaceutical, Inc.$553
- E.r. Squibb & Sons, L.L.C.$475
- Teva Pharmaceuticals USA, Inc.$457
- plus $1K from 11 others
What the payments were for
- Speaking & faculty fees$16,50070%
- Travel & lodging$7503%
- Food & beverage$6,35927%
- Education$1170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 50 | $19,337 |
| Neurocrine Biosciences, Inc. | 15 | $830 |
| Alkermes, Inc. | 11 | $678 |
| Otsuka America Pharmaceutical, Inc. | 28 | $553 |
| E.r. Squibb & Sons, L.L.C. | 12 | $475 |
| Teva Pharmaceuticals USA, Inc. | 12 | $457 |
| AbbVie | 8 | $379 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $333 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $144 |
| Vanda Pharmaceuticals Inc. | 5 | $129 |
| Collegium Pharmaceutical, Inc. | 1 | $125 |
| Indivior Inc. | 3 | $99 |
| Janssen Scientific Affairs, LLC | 1 | $73 |
| Dexcom, Inc. | 2 | $50 |
| Merck | 1 | $24 |
| Lundbeck LLC | 1 | $21 |
| Noven Therapeutics, LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$18,386
- INVEGA TRINZA$17,491
- LYBALVI$935
- INGREZZA$582
- ARISTADA$405
- COBENFY$248
- CAPLYTA$242
- SPRAVATO$139
- JORNAY PM$125
- ABILIFY MAINTENA$125
- ABILIFY ASIMTUFII$125
- Austedo XR$122
- UZEDY$119
- VRAYLAR$111
- ARISTADA INITIO$101
How this compares
$23,726 in reported general payments places this provider in the 95th percentile of 922 psychiatric/mental health providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 28 | $43,193 |
| Lurasidone Hcl | 11 | $10,968 |
| Seroquel XrQuetiapine Fumarate | 12 | $9,073 |
| Aripiprazole | 22 | $3,145 |
| Bupropion XlBupropion Hcl | 35 | $2,969 |
| Oxcarbazepine | 36 | $2,173 |
| Quetiapine Fumarate | 74 | $2,140 |
| Buspirone Hcl | 75 | $1,409 |
| Ziprasidone Hcl | 12 | $1,242 |
| Divalproex Sodium ErDivalproex Sodium | 23 | $1,076 |
| Divalproex Sodium | 24 | $806 |
| Hydroxyzine Hcl | 18 | $720 |
| Olanzapine | 39 | $557 |
| Duloxetine Hcl | 32 | $537 |
| Trazodone Hcl | 121 | $408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $379 | $43,19328 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 922 psychiatric/mental health providers in Illinois.
Other psychiatric/mental health in Joliet
- January RobinsonJoliet$6K
- Kathleen LinehanJoliet$6K
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$151K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.